Trending

lung

Eye on ESMO: Day Three – Merck & Co. wins big lung cancer battle

Eye on ESMO: Day Three – Merck & Co. wins big lung cancer battle

Merck unveils impressive data on Keytruda, trumping BMS’ Opdivo

X

Eye on ESMO: Day Three – Merck & Co. wins big lung cancer battle

https://pharmaphorum.com/esmo-2016/eye-esmo-day-three-merck-co-wins-big-lung-cancer-battle/

New data supports key AZ cancer drug

New data supports key AZ cancer drug

Tagrisso could help revive sales after patent losses.

X

New data supports key AZ cancer drug

https://pharmaphorum.com/news/new-data-supports-key-az-cancer-drug/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com